Focus: BALT is a medical device biotechnology company specializing in interventional access and treatment solutions for neurovascular diseases, operating from Irvine, CA with a focused product portfolio in intracranial aneurysm and acute stroke treatment.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Hot — 33 jobs added in 30d
Net +22 (33 new, 11 removed). Aggressive expansion phase.
Best suited for professionals seeking device-side neurovascular expertise in a growth-stage company, but limited financial transparency warrants due diligence on runway and exit trajectory.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for BALT
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from BALT's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles